论文部分内容阅读
Since the discovery of losartan[1](DUP 753), the leading non-peptide AT1 antagonist, several highly potent AT1 selective antagonists bearing heterocycles have been reported. [2] The tetrazole group is a common acidic functionpresent in many these antagoni